Exxon Scientists Had Doubts About Algae Biofuels. The Oil Giant Touted Them Anyway.
Some of the company’s scientists didn’t agree with the way the project was presented to investors.
https://www.wsj.com/business/energy-oil/exxon-algae-biofuels-83c6b302
Why does this surprise everyone? We have a bunch of downstream yo-yos running the company. Ask how much money was spent on Baytown H2, Denbury, low carbon power, etc. all with very little to no profits?
The only reason they are getting away with it is because they were gifted Guyana, Permian, etc. and because they keep firing people shrug
DW will ki-l the pension and retire with hundreds of millions and the BTC will be all that’s left to pick up the pieces!
@OP Why no one talks about RFR they ki-led it twice! Lat time they even purchased all equipment for the "Demo plant". If you can't do proper research do not waste time /energy/money just move on
Turn out the lights, the party was over before we spent $30M. At the end of the fourteen-year party, we had spent at total of $300M
Viridos: ExxonMobil's $300M Algae Biofuel Bet Ends in 64-Day Delaware Sale
Viridos chapter 11: ExxonMobil's $300M algae biofuel partnership ends. Breakthrough Energy Ventures acquired assets in 64-day Delaware sale process.
Published January 3, 2026
Updated March 6, 2026
Viridos, Inc. filed for chapter 11 after years of algae biofuel research. Founded by genomics scientist Craig Venter under the name Synthetic Genomics in 2005, the La Jolla, California-based company attracted more than $300 million from ExxonMobil over a 14-year research partnership. When ExxonMobil ended that partnership in spring 2023, declaring algae biofuels still "too difficult and expensive" for commercial viability, Viridos sought additional funding. A $25 million investment from Breakthrough Energy Ventures, United Airlines Ventures, and Chevron followed. Viridos filed for chapter 11 protection in Delaware on April 14, 2025, and completed a 64-day sale to Breakthrough Energy Ventures II before the case was dismissed in November 2025.
Viridos initially filed as a Subchapter V small business debtor but converted to a regular chapter 11 case within three days. Breakthrough Energy Ventures II served as both DIP lender and stalking horse purchaser. ExxonMobil filed a limited objection to the sale. The sale to Breakthrough Energy Ventures II was approved in June 2025, and the case was dismissed in November 2025.
Company Background and Founding
Craig Venter is a genomics scientist who led one of the first draft sequences of the human genome and led the first team to transfect a cell with a synthetic chromosome. He founded Synthetic Genomics in June 2005 with a mission to engineer microorganisms for practical applications. Based in La Jolla, California near his eponymous J. Craig Venter Institute, Synthetic Genomics initially pursued a broad portfolio: engineering algae, bacteria, and other organisms to produce biofuels, vaccines, and industrial chemicals.
The biofuels application attracted attention. Algae offered advantages as a fuel feedstock: they grow rapidly (harvesting every one to two weeks versus annual crops), contain significantly more oil per gram than terrestrial plants like oil palm or canola, and can photosynthesize carbon dioxide directly from the atmosphere. Biofuels derived from photosynthetic algae offer up to 98% emission savings compared to petroleum-based fuels. By engineering algae strains with enhanced lipid (oil) production, Synthetic Genomics aimed to develop renewable fuel pathways for aviation and other sectors.
The ExxonMobil partnership.
In July 2009, ExxonMobil entered algae biofuels research. The oil giant announced a $600 million collaboration with Synthetic Genomics to develop next-generation biofuels from photosynthetic algae.
Over the following 14 years, the collaboration produced scientific advances. In 2017, researchers from ExxonMobil and Synthetic Genomics announced research published in Nature Biotechnology, demonstrating a modified algae strain that more than doubled oil content—from 20% to over 40%—without significantly inhibiting growth. The team genetically engineered the species Nannochloropsis gaditana; strains optimized for lipid production typically grew slowly, while fast-growing strains produced less oil. A 2018 announcement targeted the technical ability to produce 10,000 barrels of algae biofuel per day by 2025, including outdoor field studies growing algae in contained ponds in California.
The partnership extended beyond Synthetic Genomics. ExxonMobil funded algae research at the Colorado School of Mines through an eight-year partnership with the Posewitz Research Group, and struck a $100 million, 10-year agreement with the National Renewable Energy Laboratory in 2019—the largest financial commitment to NREL outside government funding. Since 2009, ExxonMobil invested over $350 million on projects developing fuel from lipids in algae. The company also spent $68 million promoting its algae program through advertising, according to a congressional probe.
Rebranding to Viridos.
In September 2021, Synthetic Genomics rebranded as Viridos, a name derived from the Latin "viridis" meaning green. The rebranding coincided with a pivot toward the sustainable aviation fuel (SAF) market, narrowing focus from broad biofuels applications to aviation-specific solutions. SAF had emerged as a decarbonization pathway for aviation, with major carriers making net-zero commitments that would require large quantities of low-carbon jet fuel. Airlines including United, Delta, and European carriers began signing SAF offtake agreements, creating potential demand for algae-derived fuels.
The timing reflected broader industry trends. The EU's ReFuelEU Aviation regulation established minimum 2% sustainable aviation fuel requirements by 2025, rising to 70% by 2050. The UK established targets requiring at least 2% SAF by 2025, 10% by 2030, and 22% by 2040. The aviation industry was investing in biofuels for their potential to reduce carbon emissions by up to 80% versus conventional jet fuel. Viridos positioned itself to align with those requirements in its market focus.
ExxonMobil Exit and Funding Collapse The 2023 partnership termination.
In spring 2023, ExxonMobil ended its 14-year algae biofuels partnership with Viridos. The oil giant's spokesperson acknowledged having invested "hundreds of millions of dollars over a decade" with "remarkable results in the science, which has been peer reviewed," but concluded that algae "has not yet reached a level we believe is necessary to achieve the commercial and global scale needed." ExxonMobil shifted focus to technologies with clearer near-term commercial potential, particularly carbon capture and hydrogen, areas where substantial subsidies in the Inflation Reduction Act offered more immediate returns.
The exit affected research institutions beyond Viridos: funding ended for projects at the Colorado School of Mines and the National Renewable Energy Laboratory.
ExxonMobil had been the company's primary funder for over a decade, providing capital, technical resources, and market access. The exit left Viridos seeking alternative funding in the climate tech market.
Emergency capital raise.
Within a month of ExxonMobil's announcement, Viridos raised $25 million from Breakthrough Energy Ventures, United Airlines Ventures, and Chevron, forming a consortium of climate-focused investors and aviation industry stakeholders.
Breakthrough Energy Ventures, founded by Bill Gates in 2015, provided capital for the investment. BEV I launched in 2016 with $1 billion in commitments, followed by BEV II with $1.25 billion and BEV III with $839 million raised as of 2024. The fund's 20-year investment horizon—versus typical 5-year VC timelines—aligned with the long development cycles of deep technology like algae biofuels.
United Airlines Ventures reflected the airline industry's direct stake in sustainable aviation fuel development. United's Sustainable Flight Fund, launched in February 2023 with over $100 million, brought together Air Canada, Boeing, GE Aerospace, JPMorgan Chase, and Honeywell as partners. United had committed to invest in the future production of over five billion gallons of SAF—the most of any airline globally. The fund subsequently grew to exceed $200 million, adding partners including Air New Zealand, Google, and Safran.
Chevron Technology Ventures, through its Future Energy Funds, had invested in over 30 climate technology companies. The venture arm launched in 1999 to identify emerging technologies, with its Future Energy Fund III in 2024 committing $500 million following $400 million across the first two funds.
The $25 million round was smaller than ExxonMobil's multi-year funding.
The commercialization challenge.
Viridos faced economic obstacles common to algae biofuel ventures. Despite algae's biological advantages—rapid growth, high oil content, carbon capture—producing fuel at competitive prices proved difficult.
The core challenge involved scaling laboratory results to commercial production. Growing algae in controlled laboratory settings differed from cultivating large volumes outdoors. Open pond systems faced contamination from competing organisms. Photobioreactors maintained purity but required expensive infrastructure. Harvesting algae, extracting lipids, and converting those lipids to aviation-grade fuel each added costs that compounded to make algae fuel more expensive than petroleum-based alternatives.
https://elevenflo.com/blog/viridos-bankruptcy
Everyone at Clinton, NJ (CSR) knew how fraudulent the scientists working on BioFuels and the Management felt like (specially VJ Syrup).
The entire Clinton, CSR facility had a Theranos vibe with lecherous management pushing for fraudulent female researchers and incompetent yes men researchers.
It was the BeckMarler show and tell Lamp- Lighter baby that lasted too long. We were playing musical chairs and we were the last ones to fall on our behinds. V-J got a nice padded lump out of it.
Sure miss seeing her in those jeans in the e cafeteria, 08801, I miss Mr Frosty
Whatl emtec invent next?
LCS is total bs and a waste. Proxxima is she iet and dac is absurd.
Remember the PA guy who got caught in a fake Zoom job interview? Algae, and other programs, were just there to provide EM executives with ”talking points” when asked what the company was doing to be ‘greener’. Full stop. It was never meant to be a technically and commercially viable initiative.
light weight propoant and surfactants in Permian are snake oil